ACRO Biomedical Co., Ltd. (TPEX:6748)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
169.00
+3.00 (1.81%)
Jul 30, 2026, 9:59 AM CST

ACRO Biomedical Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
11,8224,0401,5642,4091,024939
Market Cap Growth
181.92%158.32%-35.07%135.16%9.09%-
Enterprise Value
10,8553,6001,0512,150691860
Last Close Price
166.0066.0025.2838.9419.6924.61

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
309.04105.6235.3647.1837.0743.02
PB Ratio
10.703.662.503.512.717.22
P/TBV Ratio
10.773.682.523.562.767.69

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
283.7594.1123.7542.1125.0139.40

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.010.030.030.030.10
Net Debt / Equity Ratio
-0.88-0.88-0.77-0.81-0.81-0.38
Net Debt / EBITDA Ratio
11.8311.838.3012.765.271.05
Net Debt / FCF Ratio
15.6515.656.548.066.391.03
Asset Turnover
0.040.040.060.090.100.12
Inventory Turnover
1.691.691.791.091.050.52
Quick Ratio
49.9049.9027.5839.6625.826.11
Current Ratio
51.1251.1228.6841.0427.689.01
Return on Equity (ROE)
-9.55%-9.55%-9.46%-7.78%-23.94%-32.92%
Return on Assets (ROA)
-6.45%-6.45%-5.89%-5.46%-14.27%-18.87%
Return on Capital Employed (ROCE)
-8.30%-8.30%-10.20%-6.90%-16.30%-38.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-0.70%-2.05%-3.97%-1.72%-5.94%-5.41%
FCF Yield
-0.52%-1.53%-4.73%-2.88%-4.67%-5.13%
Buyback Yield / Dilution
-0.04%-0.04%-16.17%-11.22%-33.71%-17.22%